Published in Antimicrob Agents Chemother on March 01, 1996
Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med (1997) 3.62
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother (2000) 3.28
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J Virol (1999) 2.20
Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100. J Virol (1998) 1.81
CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci U S A (2010) 1.62
CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc Natl Acad Sci U S A (2008) 1.60
Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Antimicrob Agents Chemother (1996) 1.54
CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. Cancer Res (2011) 1.42
Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals. PLoS One (2007) 1.40
In vivo imaging of ligand receptor binding with Gaussia luciferase complementation. Nat Med (2011) 1.35
Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4. J Virol (1999) 1.16
Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice. Antimicrob Agents Chemother (2000) 1.03
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects. Antimicrob Agents Chemother (2007) 1.00
Mouse models with human immunity and their application in biomedical research. J Cell Mol Med (2008) 0.99
The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis. Antimicrob Agents Chemother (2000) 0.95
Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320. Antimicrob Agents Chemother (1998) 0.85
Attenuation of cartilage pathogenesis in post-traumatic osteoarthritis (PTOA) in mice by blocking the stromal derived factor 1 receptor (CXCR4) with the specific inhibitor, AMD3100. J Orthop Res (2015) 0.83
CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis. BMC Cancer (2016) 0.76
Effectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice. Exp Hematol Oncol (2016) 0.75
HIV induces thymus depletion in vivo. Nature (1993) 3.73
Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med (1990) 3.59
The SCID-hu mouse as a model for HIV-1 infection. Nature (1993) 3.43
Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med (1993) 2.81
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother (1994) 2.26
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis (1995) 1.97
Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. Proc Natl Acad Sci U S A (1992) 1.89
Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. J Virol (1994) 1.87
The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. J Virol (1996) 1.69
Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent. J Immunol (1991) 1.65
Pharmacokinetics of nevirapine: initial single-rising-dose study in humans. Antimicrob Agents Chemother (1993) 1.62
Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Antimicrob Agents Chemother (1996) 1.54
Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. J Immunol (1991) 1.26
Antiviral therapy: current concepts and practices. Clin Microbiol Rev (1992) 0.96
Quantitative structural activity relationship study of bis-tetraazacyclic compounds. A novel series of HIV-1 and HIV-2 inhibitors. J Med Chem (1995) 0.86
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature (1986) 8.36
Emergence of vancomycin-resistant enterococci in New York City. Lancet (1993) 7.37
Adenomas of the Islands of Langerhans. Am J Pathol (1926) 6.98
Functional association of cyclophilin A with HIV-1 virions. Nature (1994) 6.82
A Malignant Tumor Simulating Bone Marrow. Am J Pathol (1928) 5.63
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N Engl J Med (2001) 5.33
Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med (1999) 4.74
Infection of the SCID-hu mouse by HIV-1. Science (1988) 4.37
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods (2001) 4.25
Tumors of Sebaceous Glands. Am J Pathol (1943) 4.02
Carcinoma of ceruminous gland. Am J Pathol (1941) 3.96
The Pathology of Diabetes, with Special Reference to Pancreatic Regeneration. Am J Pathol (1925) 3.79
HIV induces thymus depletion in vivo. Nature (1993) 3.73
A transplantable insulinoma in the rat. Proc Natl Acad Sci U S A (1977) 3.70
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med (2001) 3.69
Tumors of Sweat Glands. Am J Pathol (1943) 3.62
Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med (1990) 3.59
CARCINOMA OF THE THYROID. Ann Surg (1940) 3.52
A Readily Cultivable Vibrio, Filterable through Berkefeld "V" Candles, Vibrio Percolans (New Species). J Bacteriol (1923) 3.17
Fat Embolism. Am J Pathol (1946) 2.97
A full genome search in multiple sclerosis. Nat Genet (1996) 2.96
Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med (1993) 2.81
Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol (1984) 2.79
Chondrosarcoma with Intravascular Growth and Tumor Emboli to Lungs. Am J Pathol (1931) 2.60
A population-based study of multiple sclerosis in twins. N Engl J Med (1986) 2.59
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS (2001) 2.47
PRIMARY, SOLITARY LYMPHOID TUMORS OF THE GASTRO-INTESTINAL TRACT. Ann Surg (1942) 2.47
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci U S A (2002) 2.46
Benign tumors of the liver. Med Clin North Am (1975) 2.38
Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med (1998) 2.27
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother (1994) 2.26
Structure of RNA and RNA binding site in tobacco mosaic virus from 4-A map calculated from X-ray fibre diagrams. Nature (1977) 2.20
Generalized Amyloidosis of the Muscular Systems. Am J Pathol (1930) 2.16
Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Nat Med (2001) 2.13
HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity (1995) 2.07
The Angle of the Mitotic Spindles in Malignant Cells. Am J Pathol (1933) 2.07
Suppression of HIV infection in AZT-treated SCID-hu mice. Science (1990) 1.97
Bile duct adenoma. A study of 152 cases. Am J Surg Pathol (1988) 1.87
Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. J Virol (1994) 1.87
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer (1985) 1.82
Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem (2001) 1.81
A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol (1998) 1.79
Interstitial Cell Growths of the Testicle. Am J Pathol (1943) 1.78
Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigen. J Exp Med (1976) 1.74
Incomplete particles of adenovirus. II. Kinetics of formation and polypeptide composition of adenovirus type 2. Virology (1974) 1.74
CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. J Virol (1998) 1.72
Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc Natl Acad Sci U S A (1993) 1.70
Association of Other Malignant Tumors With Cancer of the Skin. Am J Public Health Nations Health (1943) 1.70
Pheochromocytoma. Cancer (1972) 1.70
Direct evidence for thymic function in adult humans. J Exp Med (1999) 1.70
Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent. J Immunol (1991) 1.65
CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation. J Immunol (1998) 1.64
The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu Rev Immunol (1991) 1.63
Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J Virol (1996) 1.61
Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice. J Exp Med (1999) 1.61
Reticulum cell sarcoma of lymph nodes. Am J Pathol (1941) 1.60
Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Antimicrob Agents Chemother (1996) 1.54
Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol (1991) 1.51
Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J Immunol (1995) 1.50
Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women? Hepatology (1984) 1.49
Multiple sclerosis in childhood: clinical profile in 125 patients. J Pediatr (1987) 1.48
Two types of Ia-positive T cells. Synthesis and exchange of Ia antigens. J Exp Med (1980) 1.47
A population-based study of multiple sclerosis in twins: update. Ann Neurol (1993) 1.46
Calcium regulation of growth and differentiation of normal human keratinocytes: modulation of differentiation competence by stages of growth and extracellular calcium. J Cell Physiol (1990) 1.44
A STUDY OF THE MECHANISM OF NUCLEINATE-INDUCED LEUCOPENIC AND LEUCOCYTIC STATES, WITH SPECIAL REFERENCE TO THE RELATIVE ROLES OF LIVER, SPLEEN, AND BONE MARROW. J Exp Med (1928) 1.44
Insertion mutations in the control region of the Gal operon of E. coli. I. Biological characterization of the mutations. Mol Gen Genet (1972) 1.44
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J Infect Dis (2000) 1.43
Extra intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease. Gut (1985) 1.43
A WBAN System for Ambulatory Monitoring of Physical Activity and Health Status: Applications and Challenges. Conf Proc IEEE Eng Med Biol Soc (2005) 1.43
[Injury prevention in the elderly population]. Unfallchirurg (2002) 1.40
BLOOD PIGMENTS IN PERNICIOUS ANEMIA. J Clin Invest (1925) 1.40
The Vaginal Smear in Diagnosis of Carcinoma of the Uterus. Am J Pathol (1945) 1.39
The Etiology of Acute Appendicitis. Am J Pathol (1925) 1.38
In vivo diagnosis of cervical intraepithelial neoplasia using 337-nm-excited laser-induced fluorescence. Proc Natl Acad Sci U S A (1994) 1.38
Rapid insorption of small particles in the gut. Am J Gastroenterol (1990) 1.37
T cell turnover in HIV-1 disease. Immunity (1997) 1.35
Increasing incidence of adenocarcinoma of the lung. Cancer (1981) 1.35
Tryptic fingerprint analysis of adenovirus types 2, 5 and 12 DNA-Binding proteins. Virology (1976) 1.35
Adenovirus-infected, cell-specific, DNA-binding proteins. Cold Spring Harb Symp Quant Biol (1975) 1.34
Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. J Infect Dis (2001) 1.32
Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood (1992) 1.31
Pathology and Pathologic Diagnosis of Radiation Lesions in the Gastro-Intestinal Tract. Am J Pathol (1942) 1.29
Molecular biology of pyridine nucleotide biosynthesis in Escherichia coli. Cloning and characterization of quinolinate synthesis genes nadA and nadB. Eur J Biochem (1988) 1.28
Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-linked agammaglobulinemia. J Exp Med (1980) 1.28
Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. J Immunol (1991) 1.26
Early processes of echovirus 12-infection: elution, penetration, and uncoating under the influence of rhodanine. Virology (1979) 1.24
Propagation of fluorescent light. Lasers Surg Med (1997) 1.24
Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. Virology (2001) 1.23
Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses. J Virol (1986) 1.23
Metastatic Carcinoma Simulating Hyperparathyroidism. Am J Pathol (1931) 1.22